CA2946618A1 - Derives ii du 3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5h)-yle - Google Patents

Derives ii du 3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5h)-yle Download PDF

Info

Publication number
CA2946618A1
CA2946618A1 CA2946618A CA2946618A CA2946618A1 CA 2946618 A1 CA2946618 A1 CA 2946618A1 CA 2946618 A CA2946618 A CA 2946618A CA 2946618 A CA2946618 A CA 2946618A CA 2946618 A1 CA2946618 A1 CA 2946618A1
Authority
CA
Canada
Prior art keywords
alkyl
furo
chloro
pyrrol
oxoethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2946618A
Other languages
English (en)
Inventor
Antonio Nardi
Paul Ratcliffe
Tobias CRAAN
Thorsten HERTRAMPF
Bernhard Lesch
Henning Steinhagen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of CA2946618A1 publication Critical patent/CA2946618A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2946618A 2014-04-23 2015-04-23 Derives ii du 3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5h)-yle Abandoned CA2946618A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14001458 2014-04-23
EP14001458.0 2014-04-23
PCT/EP2015/000839 WO2015161924A1 (fr) 2014-04-23 2015-04-23 Dérivés ii du 3-oxo-tétrahydro-furo[3,2-b]pyrrol-4(5h)-yle

Publications (1)

Publication Number Publication Date
CA2946618A1 true CA2946618A1 (fr) 2015-10-29

Family

ID=50677909

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2946618A Abandoned CA2946618A1 (fr) 2014-04-23 2015-04-23 Derives ii du 3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5h)-yle

Country Status (6)

Country Link
US (1) US9802947B2 (fr)
EP (1) EP3134414A1 (fr)
AR (1) AR100177A1 (fr)
CA (1) CA2946618A1 (fr)
TW (1) TW201620915A (fr)
WO (1) WO2015161924A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR114422A1 (es) 2018-03-30 2020-09-02 Syngenta Participations Ag Compuestos herbicidas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070117785A1 (en) 2000-08-14 2007-05-24 Butler Christopher R Substituted pyrazoles and methods of treatment with substituted pyrazoles
GB0614052D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0804702D0 (en) 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds

Also Published As

Publication number Publication date
TW201620915A (zh) 2016-06-16
US20150307506A1 (en) 2015-10-29
US9802947B2 (en) 2017-10-31
EP3134414A1 (fr) 2017-03-01
AR100177A1 (es) 2016-09-14
WO2015161924A1 (fr) 2015-10-29

Similar Documents

Publication Publication Date Title
CA3124898C (fr) Intermediaire de compose heterocyclique, son procede de preparation et son utilisation
EP2842955B1 (fr) Composé inhibiteur de trk
JP2020143112A (ja) セリンプロテアーゼ阻害剤としてのピラゾリル置換ピリドン化合物
TWI546287B (zh) 新穎菸鹼醯胺衍生物或其鹽
JPH0789958A (ja) ４−アミノピリミジン誘導体、その製造方法およびそれを含有する医薬品
KR20140040774A (ko) 이미다조피리딘 화합물
US20080032992A1 (en) New Pyridine Analogues V
CA2734415A1 (fr) Derives de picolinamide en tant qu'inhibiteurs de kinase
WO2018049296A1 (fr) Inhibiteurs hétéroaryles de pad4
JP2001504113A (ja) ファクターＸａを阻害する複素環式化合物誘導体
EP2375899A1 (fr) Composés contenant de la pipéridine et leurs utilisations
CN107207489A (zh) 作为nadph氧化酶抑制剂的酰氨基噻二唑衍生物
JP6892858B2 (ja) 第ＸＩａ因子阻害剤
AU2014274354A1 (en) Dihydropyridinone MGAT2 inhibitors
JP2014511355A (ja) ヒストンデアセチラーゼ阻害薬並びにその組成物及び使用方法
WO2010109122A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique comme anticancereux
MXPA06006532A (es) Derivados de naftiridina y su uso como moduladores de receptores muscarinicos.
TW201408628A (zh) 組蛋白去乙醯酶抑制劑及組成物，暨其使用之方法
WO2019178324A1 (fr) Composés d'amide d'amino-benzoisothiazole et d'amino-benzoisothiadiazole
AU2023207390A1 (en) Six-membered cyclothiazole compound and use thereof
CA3195032A1 (fr) Preparation de derives d'oxindole servant de nouveaux inhibiteurs de diacylglyceride o-acyltransferase 2
CA2946618A1 (fr) Derives ii du 3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5h)-yle
KR20220156890A (ko) Phd 억제제 화합물, 조성물, 및 용도
US9725459B2 (en) 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I
UA71952C2 (en) Urea aromatic derivatives as antiinflammatory agents

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20190423